BRIEF published on 01/20/2026 at 15:58, 1 month 27 days ago Kopernik Global Investors crosses thresholds at EUROAPI Voting Rights Actions Crossing Thresholds EUROAPI Kopernik Global Investors
BRIEF published on 12/10/2025 at 17:50, 3 months 6 days ago Tristan Imbert Appointed as Independent Director at EUROAPI Pharmaceutical Industry Independent Director Audit Committee EUROAPI Tristan Imbert
PRESS RELEASE published on 12/10/2025 at 17:45, 3 months 6 days ago Tristan Imbert co-opted as Independent Director Tristan Imbert appointed Independent Director at EUROAPI, bringing expertise in pharmaceutical finance and strategy. Financial agenda includes FY 2025 results on 3 March 2026 and 2026 AGM on 27 May 2026 Financial Agenda Strategy EUROAPI Tristan Imbert Pharmaceutical Finance
BRIEF published on 09/18/2025 at 07:05, 5 months 29 days ago Science Based Targets initiative Validates EUROAPI's Climate Goals Sustainability GHG Emissions EUROAPI Climate Goals SBTi Validation
PRESS RELEASE published on 09/18/2025 at 07:00, 5 months 29 days ago Science Based Targets initiative (SBTi) validates EUROAPI’s near-term climate targets EUROAPI's near-term climate targets validated by the Science Based Targets initiative (SBTi) show significant reductions in greenhouse gas emissions, confirming alignment with the Paris Agreement Greenhouse Gas Emissions Science Based Targets Initiative Climate Targets Paris Agreement EUROAPI
BRIEF published on 06/30/2025 at 18:03, 8 months 16 days ago EUROAPI Divests Haverhill Site to Particle Dynamics Pharmaceutical EUROAPI FOCUS-27 Haverhill Sale Particle Dynamics
PRESS RELEASE published on 06/30/2025 at 17:58, 8 months 16 days ago EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan. Deal strengthens capabilities, market reach Acquisition EUROAPI FOCUS-27 Particle Dynamics Haverhill
BRIEF published on 06/19/2025 at 16:29, 8 months 27 days ago Goldman Sachs Crosses Thresholds in EUROAPI Voting Rights Actions Goldman Sachs Threshold Crossing EUROAPI
BRIEF published on 06/06/2025 at 16:03, 9 months 10 days ago EUROAPI General Assembly: Approval of Resolutions and Perspectives General Assembly EUROAPI Resolutions Approved R&D And CDMO Outlook 2023
BRIEF published on 06/04/2025 at 17:50, 9 months 12 days ago EUROAPI appoints Frédéric Robert as Sales Director for API and CDMO CDMO Appointment EUROAPI Frédéric Robert API Solutions
Published on 03/16/2026 at 22:30, 9 hours 9 minutes ago Core Silver Intersects High-Grade Copper-Molybdenum Veins up to 7.31% Cu & 1.01% Mo Confirming Large Porphyry System at Laverdiere
Published on 03/16/2026 at 22:00, 9 hours 39 minutes ago Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
Published on 03/16/2026 at 21:30, 10 hours 9 minutes ago Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Published on 03/16/2026 at 21:00, 10 hours 39 minutes ago Amdocs Brings AI-Accelerated Application Modernization to Enterprises with NVIDIA
Published on 03/17/2026 at 07:05, 34 minutes ago Sequential™ Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing and Next-Generation Skin Health Ingredients
Published on 03/17/2026 at 07:03, 36 minutes ago Sartorius Stedim Biotech sharpens strategy with biopharma focus and sets new mid-term growth targets
Published on 03/17/2026 at 07:00, 39 minutes ago PolyPeptide publishes invitation to the annual General Meeting 2026
Published on 03/17/2026 at 07:00, 39 minutes ago Very strong business performance delivered in 2025. Continued growth expected in 2026
Published on 03/17/2026 at 06:59, 40 minutes ago Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets
Published on 03/17/2026 at 07:00, 39 minutes ago Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 13 hours 39 minutes ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 13 hours 41 minutes ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 13 hours 42 minutes ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
